IL158056A0 - Chemical derivatives and their use as anti-telomerase agent - Google Patents
Chemical derivatives and their use as anti-telomerase agentInfo
- Publication number
- IL158056A0 IL158056A0 IL15805602A IL15805602A IL158056A0 IL 158056 A0 IL158056 A0 IL 158056A0 IL 15805602 A IL15805602 A IL 15805602A IL 15805602 A IL15805602 A IL 15805602A IL 158056 A0 IL158056 A0 IL 158056A0
- Authority
- IL
- Israel
- Prior art keywords
- chemical derivatives
- telomerase agent
- telomerase
- agent
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0103916A FR2822468B1 (en) | 2001-03-23 | 2001-03-23 | CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTI-TELOMERASE AGENT |
| FR0110370 | 2001-08-02 | ||
| PCT/FR2002/001005 WO2002076975A1 (en) | 2001-03-23 | 2002-03-22 | Chemical derivatives and their use as anti-telomerase agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL158056A0 true IL158056A0 (en) | 2004-03-28 |
Family
ID=26212933
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15805602A IL158056A0 (en) | 2001-03-23 | 2002-03-22 | Chemical derivatives and their use as anti-telomerase agent |
| IL158056A IL158056A (en) | 2001-03-23 | 2003-09-22 | Chemical derivatives and pharmaceutical compositions containing them for use as anti-telomerase agent |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL158056A IL158056A (en) | 2001-03-23 | 2003-09-22 | Chemical derivatives and pharmaceutical compositions containing them for use as anti-telomerase agent |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1373252A1 (en) |
| JP (1) | JP2004524349A (en) |
| AR (1) | AR034297A1 (en) |
| AU (1) | AU2002251140B2 (en) |
| CA (1) | CA2442012A1 (en) |
| CO (1) | CO5380035A1 (en) |
| IL (2) | IL158056A0 (en) |
| MX (1) | MXPA03008269A (en) |
| MY (1) | MY130957A (en) |
| PE (1) | PE20020959A1 (en) |
| WO (1) | WO2002076975A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002314252A1 (en) | 2001-05-28 | 2002-12-09 | Aventis Pharma S.A. | Chemical derivatives and the use thereof as an anti-telomerase agent |
| US7173032B2 (en) * | 2001-09-21 | 2007-02-06 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| AU2002361846A1 (en) * | 2001-12-21 | 2003-07-15 | Bayer Pharmaceuticals Corporation | Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents |
| WO2004001018A2 (en) * | 2002-06-25 | 2003-12-31 | The Center For Blood Research, Inc. | Vacuolins |
| FR2850970B1 (en) * | 2003-02-07 | 2006-07-07 | Aventis Pharma Sa | CHEMICAL DERIVATIVES BINDING VERY SPECIFIC TO G-QUADRUPLEX DNA STRUCTURES AND THEIR APPLICATION AS A SPECIFIC ANTICANCER AGENT |
| US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
| EP1833482A4 (en) | 2005-01-03 | 2011-02-16 | Myriad Genetics Inc | Compounds and therapeutical use thereof |
| US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
| NZ563245A (en) * | 2005-05-19 | 2011-04-29 | Prometic Biosciences Inc | Triazine compounds and compositions thereof for the treatment of cancers |
| JP2009545592A (en) * | 2006-07-31 | 2009-12-24 | プリーシス・ファーマシューティカルズ・インコーポレイテッド | Aurora kinase inhibitors from encoded small molecule libraries |
| WO2009015254A1 (en) * | 2007-07-25 | 2009-01-29 | Bristol-Myers Squibb Company | Triazine kinase inhibitors |
| FR2948686B1 (en) * | 2009-07-30 | 2011-08-19 | Biomerieux Sa | NEW PEPTIDASE SUBSTRATES |
| JP7284518B2 (en) * | 2018-03-20 | 2023-05-31 | 国立大学法人広島大学 | Compound that inhibits telomere-binding protein, and telomere-binding protein inhibitor containing the same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9206768D0 (en) * | 1992-03-27 | 1992-05-13 | Jarman Michael | New compounds for use in the treatment of cancer |
| JPH1160573A (en) * | 1997-08-22 | 1999-03-02 | Nippon Kayaku Co Ltd | Triazine derivative and telomerase inhibitor |
| US6262053B1 (en) * | 1999-06-23 | 2001-07-17 | Parker Hughes Institute | Melamine derivatives as potent anti-cancer agents |
| CZ20021849A3 (en) * | 1999-11-29 | 2002-08-14 | Aventis Pharma S. A. | Chemical derivatives and their use as anti-telomerase agents |
| CN102151273B (en) * | 2002-02-05 | 2015-11-25 | 安斯泰来制药有限公司 | 2,4,6-triamino-1,3,5-triazine derivative |
-
2002
- 2002-03-21 CO CO02025874A patent/CO5380035A1/en not_active Application Discontinuation
- 2002-03-22 IL IL15805602A patent/IL158056A0/en unknown
- 2002-03-22 PE PE2002000227A patent/PE20020959A1/en not_active Application Discontinuation
- 2002-03-22 AU AU2002251140A patent/AU2002251140B2/en not_active Ceased
- 2002-03-22 JP JP2002576233A patent/JP2004524349A/en not_active Ceased
- 2002-03-22 MX MXPA03008269A patent/MXPA03008269A/en not_active Application Discontinuation
- 2002-03-22 EP EP02720068A patent/EP1373252A1/en not_active Withdrawn
- 2002-03-22 WO PCT/FR2002/001005 patent/WO2002076975A1/en active IP Right Grant
- 2002-03-22 MY MYPI20021036A patent/MY130957A/en unknown
- 2002-03-22 CA CA002442012A patent/CA2442012A1/en not_active Abandoned
- 2002-03-22 AR ARP020101060A patent/AR034297A1/en unknown
-
2003
- 2003-09-22 IL IL158056A patent/IL158056A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AR034297A1 (en) | 2004-02-18 |
| EP1373252A1 (en) | 2004-01-02 |
| WO2002076975A1 (en) | 2002-10-03 |
| IL158056A (en) | 2010-02-17 |
| PE20020959A1 (en) | 2002-12-17 |
| CA2442012A1 (en) | 2002-10-03 |
| CO5380035A1 (en) | 2004-03-31 |
| JP2004524349A (en) | 2004-08-12 |
| MY130957A (en) | 2007-07-31 |
| MXPA03008269A (en) | 2004-10-15 |
| AU2002251140B2 (en) | 2007-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1078266A1 (en) | Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same | |
| AUPR879601A0 (en) | Novel chemical compounds and their use | |
| MXPA03006260A (en) | Substituted amine derivatives and methods of use. | |
| ZA200300545B (en) | Novel heteroaryl derivatives and use thereof as anti-tumour agents. | |
| IL150701A0 (en) | 4-aminopicolinates and their use as herbicides | |
| AU8729901A (en) | Benzoylpyrazols and their use as herbicides | |
| AU2002358700A8 (en) | Urea derivatives as vr1- antagonists | |
| AU2002314252A1 (en) | Chemical derivatives and the use thereof as an anti-telomerase agent | |
| HUP0402025A3 (en) | Novel bensophenone derivatives or salts thereof and their use | |
| HUP0401756A3 (en) | Substituted benzimidazole compounds and their use | |
| IL158056A0 (en) | Chemical derivatives and their use as anti-telomerase agent | |
| AU2002251140A1 (en) | Chemical derivatives and their use as anti-telomerase agent | |
| GB0126889D0 (en) | Compounds and their uses | |
| AUPR879701A0 (en) | Novel chemical compounds and their use | |
| HUP0500734A3 (en) | Use of 2-alkoxyphenyl-substituted imidazotriazinones | |
| HUP0600238A2 (en) | Benzothiazole- and benzoxazole-4,7-dione derivatives and their use | |
| EP1392317A4 (en) | Substituted 1-benzazepines and derivatives thereof | |
| HK1066022A1 (en) | Use of 1,1,1,3,3-pentafluorobutan | |
| HUP0401162A3 (en) | Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives | |
| IL156794A0 (en) | Chemical derivatives and their use as anti-telomerase agent | |
| AU2002229859A1 (en) | Chemical derivatives and their use as anti-telomerase agent | |
| AU2001282268A1 (en) | Phenantridine derivatives and their use as anti-telomerase agent | |
| EP1367123A4 (en) | Neurotonin and use thereof | |
| GB0122162D0 (en) | Agent | |
| GB0106987D0 (en) | Immunotherapeuitic agent |